Casís Herce, Begoña Martínez Montiel, Pilar
Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience [artículo] - Gastroenterologia y Hepatologia, 2011. - 34(7):443-448.
Formato Vancouver:
Fortea-Ormaechea JI, González-Lama Y, Casis B, Chaparro M, López Serrano P, Van Domselaar M, et al. Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience. Gastroenterol Hepatol. 2011;34(7):443-8.
PMID: 21724297
Contiene 19 referencias.
Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience [artículo] - Gastroenterologia y Hepatologia, 2011. - 34(7):443-448.
Formato Vancouver:
Fortea-Ormaechea JI, González-Lama Y, Casis B, Chaparro M, López Serrano P, Van Domselaar M, et al. Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience. Gastroenterol Hepatol. 2011;34(7):443-8.
PMID: 21724297
Contiene 19 referencias.
